Influence of inhibitory inputs on rate and timing of responses in the anteroventral cochlear nucleus.
Anatomical and physiological studies have shown that anteroventral cochlear nucleus (AVCN) neurons receive glycinergic and GABAergic inhibitory inputs. In this study, changes in the temporal responses of AVCN neurons to pure tones and complex sounds after blocking inhibition were analyzed. Blocking inhibition influenced the temporal responses of each type of AVCN neuron. Choppers showed more chopping peaks and shortened chopping cycles after blocking inhibition. Sustained and slowly adapting choppers showed increased regularity throughout the response duration after blocking inhibition, whereas most transient choppers showed increased regularity in the early part of the response. Diverse changes in temporal response patterns were observed in neurons with primary-like and unusual responses, with several neurons showing a large decrease in the first-spike latency after blocking inhibition. This result disagreed with previous findings that onset responses are less affected than sustained responses by manipulating inhibition. Although blocking inhibition had a greater effect on spontaneous activity than that on tone-evoked activity, the change in spontaneous activity was less significant because of larger variability. In addition, for relatively high level masker noises, blocking inhibition had similar effects on responses to noise-alone and noise-plus-tone stimuli, in contrast with previous studies with low-level background noise. In general, inhibition had an enhancing effect on temporal contrast only for responses to amplitude-modulated tones, for which envelope synchrony was enhanced. Results of this study contribute new information about the characteristics, functional roles, and possible sources of inhibitory inputs received by AVCN neurons.
Gai
Yan
Y
Department of Biomedical and Chemical Engineering, Syracuse University, Syracuse, NY, USA.
Carney
Laurel H
LH
D000161:Acoustic Stimulation / Q000379:methods; D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D000818:Animals; D001640:Bicuculline / Q000494:pharmacology; D017626:Cochlear Nucleus / Q000166:cytology*; D018756:GABA Antagonists / Q000494:pharmacology; D005849:Gerbillinae; D018684:Glycine Agents / Q000494:pharmacology; D007478:Iontophoresis / Q000379:methods; D009433:Neural Inhibition / Q000187:drug effects / Q000502:physiology*; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D011724:Pyridazines / Q000494:pharmacology; D011930:Reaction Time / Q000187:drug effects / Q000502:physiology*; D013331:Strychnine / Q000494:pharmacology; D013997:Time Factors
D018756:GABA Antagonists; D018684:Glycine Agents; D011724:Pyridazines; C049853:gabazine; D013331:Strychnine; D001640:Bicuculline